Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer. - Knox JJ; O'Kane G; King D; Laheru D; Habowski AN; Yu K; Perez K; Aguirre AJ; Coyne Z; Harvey H; McLaughlin RA; Jang RW; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)